Keir International Company announces the appointment of a financial advisor for the reduction of the Company's share capital

Element List	Explanation
Introduction	Keir International Company announces the appointment of Estidamah Alamaal Capital Company (“Estidamah Capital”) as its financial advisor, on 15/02/1448H (corresponding to 29/07/2026G), based on the Board of Directors' recommendation to restructure the Company's share capital, to undertake the necessary procedures and studies in connection with the reduction of the Company's share capital and to submit the necessary recommendations in this regard.
Name of Financial Advisor	Estidamah Alamaal Capital Company
Financial Advisor Appointment Date	2026-07-29 Corresponding to 1448-02-15
Additional Information	Reason for Appointment: Appointment of a financial advisor to conduct the necessary studies and submit recommendations relating to the reduction of the Company's share capital, in furtherance of the Board of Directors' recommendation regarding the restructuring of the Company's capital. Financial Impact: The appointment of the financial advisor does not have any material financial impact at the present time. The Company is awaiting the issuance of its financial results for the first half of the year in order to determine the final financial impact associated with the capital reduction process, and will disclose this once available. Regulatory Procedures: The Company will take all necessary regulatory measures in this regard in accordance with the provisions of the Companies Law and its Implementing Regulations, the Rules on the Offer of Securities and Continuing Obligations issued by the Capital Market Authority, and the Listing Rules issued by the Saudi Stock Exchange (Tadawul). Additional Information: The agreement entered into with Estidamah Capital includes studying the appropriate options and procedures for reducing the Company's share capital in a manner that supports and strengthens its financial position. The Company will disclose any material developments, including the details of the capital reduction and the results of the studies, in accordance with the relevant laws and regulations and after obtaining the necessary regulatory approvals.